Barrett's Esophagus

Barrett's Esophagus gives an extensive overview written by the world's leading experts covering the epidemiology, gastroenterology and surgery, as well as the molecular basis of: the precursor lesions leading to the development of Barrett's epithelium; the unique characteristics of Barrett's esophagus; the consequences of malignant degeneration, i.e. adenocarcinoma. All aspects in terms of diagnosis, secondary prevention, multimodality, medical and surgical treatment are elucidated.

Contributors. Preface. Norman Barrett and the esophagus
R.V.N. Lord.
Section 1: Normal Anatomy and Physiology of the esophagus. 1.1. Embryology and anatomy of the esophagus
D. Liebermann-Meffert. 1.2. Cell biology of the esophageal epithelium
S.E.A. Attwood, C.D. Morris. 1.3. Normal physiology of the esophagus
P.M.A. Fisichella, M.G. Patti. 1.4. Pathophysiology of the lower esophageal spincter
A.J.P.M. Smout.
Section 2: Gastro-Esophageal Reflux Disease. 2.1. Natural history of reflux disease
B. Johnston, A.H.G. Love DAGGER. 2.2. H. Pylori and reflux disease
A. Cats, E.J. Kuipers. 2.3. Acid and bile in the esophagus
W.J. Owen, R.E.K. Marshall. 2.4. Endoscopic classification of G.E.R.D.
J. Hatlebakk, A. Berstad. 2.5. Optimal surgery for reflux disease
G.G. Jamieson, D.I. Watson. 2.6. Surgical treatment of duodeno gastro-esophageal reflux disease
A. Csendes, P. Buldiles, O. Korn.
Section 3: Barrett's Esophagus - Diagnosis. 3.1. Histopathology
H. van Dekken. 3.2. The metaplasia - dysplasia sequence
A. Woodman, J.J.A. Jankowski, N. Shepherd. 3.3. Genetic alterations
B.P.L. Wijnhoven, W.N.M. Dinjens. 3.4. Endoscopic surveillance
R.E. Sampliner. 3.5. Short segment Barrett's esophagus and metaplasia at the gastro-esophageal junction
S.R. Preston, G.W. Clark.
Section 4: Barrett's Esophagus - Treatment. 4.1. Prevention of cancer by control of reflux
L. Lundell. 4.2. Prevention of cancer in Barrett's by ablation
J.P. Byrne, S.E.A. Attwood. 4.3. The role of ablation in the management of high grade dysplasia
H. Barr. 4.4. Surgical treatment of high grade dysplasia and superficial carcinoma
M. de Jong, H.W. Tilanus.
Section 5: Adenocarcinoma in Barrett's. 5.1. Epidemiology
A. Cameron. 5.2. Signs, symptoms and endoscopic appearance
G.W. Falk. 5.3. Classification and staging
A.H. Holscher, W. Schroder, S.P. Monig. 5.4. Diagnosis and implications of bone marrow micrometastases
D. Maguire, F. Shanahan, G.G. O'Sullivan.
Section 6: Treatment of Adenocarcinoma. 6.1. Indications and outcome of esophageal resection
T. Lerut. 6.2. Transhiatal esophagectomy
J.R. Bumm, J.R. Siewert. 6.3. Resection of esophageal carcinoma: the role of lymfnode dissection
J.B.F. Hulscher, J.J.B. van Lanschot. 6.4. Videoendoscopic esophagectomy for cancer
J.M. Collard. 6.5. Management of postoperative complications
V. Rempe-Sorm, H.W. Tilanus. 6.6. Multimodality in the management of adenocarcinoma of the esophagus
AS. DeNittis, et al. 6.6. Endoscopic management of dysphagia from esophageal cancer
P.D. Siersema. Section 7: Quality of Life. 7.1. Function and quality of life after esophageal resection
C. Deschamps.